XML 52 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Number of Common Shares Reserved for Issuance
The number of common shares reserved for issuance under the 2019 Plan are as follows: 
(in millions)December 31,
20222021
Shares available for granting 1
19.319.5
Options outstanding0.20.3
Total shares reserved for issuance19.519.8
1 Shares reserved for issuance under the Director Plan are less than 1.0 million at both December 31, 2022 and 2021.
Schedule of Stock-based Compensation Expense
Stock-based compensation expense and the corresponding tax benefit are as follows: 
(in millions)Year Ended December 31,
 202220212020
Stock option expense$ $— $— 
Restricted stock and other stock-based awards expense 214 122 90 
Total stock-based compensation expense$214 $122 $90 
Tax benefit$38 $20 $15 
Schedule of Stock Option Activity
Stock option activity is as follows: 
(in millions, except per award amounts)SharesWeighted average exercise priceWeighted-average remaining years of contractual termAggregate intrinsic value
Options outstanding as of December 31, 2021
0.3 $67.14 
Assumed 1
— $97.29 
Exercised(0.1)$80.88 
Options outstanding as of December 31, 2022
0.2 $68.02 1.01$67 
Options exercisable as of December 31, 2022
0.2 $68.02 1.01$67 
1 There are less than 0.1 million options that were assumed as part of the merger with IHS Markit.
Schedule of Stock Option Exercises
Information regarding our stock option exercises is as follows: 
(in millions)Year Ended December 31,
 202220212020
Net cash proceeds from the exercise of stock options$$13 $16 
Total intrinsic value of stock option exercises$13 $41 $60 
Income tax benefit realized from stock option exercises$$11 $13 
Schedule of Restricted Stock and Unit Activity
Restricted stock and other stock-based award activity is as follows: 
(in millions, except per award amounts)SharesWeighted-average grant-date fair value
Balance as of December 31, 2021
0.5 $299.28 
Assumed0.9 $380.89 
Granted 0.7 $384.65 
Vested(0.4)$355.82 
Forfeited(0.1)$372.36 
Balance as of December 31, 2022
1.6 $364.50 
Total unrecognized compensation expense related to restricted awards$132 
Weighted-average years to be recognized over1.5

 Year Ended December 31,
 202220212020
Weighted-average grant-date fair value per award$384.65 $296.49 $232.92 
Total fair value of restricted stock and other stock-based awards vested$146 $243 $134 
Tax benefit relating to restricted award activity$30 $48 $26